|
|
|
Volumn 119, Issue 1, 2001, Pages 37-40
|
|
Diabetic dyslipoproteinemia: physiopathological bases and treatment prospects;Diabetische Dyslipoproteinämie. Pathophysiologische Grundlagen und therapeutische Perspektiven.
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
2,4 THIAZOLIDINEDIONE DERIVATIVE;
ANTIDIABETIC AGENT;
ANTILIPEMIC AGENT;
CHROMAN DERIVATIVE;
HIGH DENSITY LIPOPROTEIN CHOLESTEROL;
HYPOCHOLESTEROLEMIC AGENT;
INSULIN;
LOW DENSITY LIPOPROTEIN CHOLESTEROL;
SIMVASTATIN;
THIAZOLE DERIVATIVE;
TROGLITAZONE;
ARTICLE;
BLOOD;
CLINICAL TRIAL;
COMPARATIVE STUDY;
CORONARY ARTERY DISEASE;
DIABETES MELLITUS;
GLUCOSE BLOOD LEVEL;
HUMAN;
HYPERLIPOPROTEINEMIA;
HYPERTRIGLYCERIDEMIA;
INSULIN DEPENDENT DIABETES MELLITUS;
MALE;
NON INSULIN DEPENDENT DIABETES MELLITUS;
PATHOPHYSIOLOGY;
RISK FACTOR;
ANTICHOLESTEREMIC AGENTS;
ANTILIPEMIC AGENTS;
BLOOD GLUCOSE;
CHOLESTEROL, HDL;
CHOLESTEROL, LDL;
CHROMANS;
CLINICAL TRIALS;
CORONARY DISEASE;
DIABETES COMPLICATIONS;
DIABETES MELLITUS;
DIABETES MELLITUS, TYPE 1;
DIABETES MELLITUS, TYPE 2;
HUMANS;
HYPERLIPOPROTEINEMIAS;
HYPERTRIGLYCERIDEMIA;
HYPOGLYCEMIC AGENTS;
INSULIN;
MALE;
RISK FACTORS;
SIMVASTATIN;
THIAZOLES;
THIAZOLIDINEDIONES;
|
|
EID: 0035749920
PISSN: None
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
|
Times cited : (2)
|
|
References (0)
|
